Erratum: Quetiapine-induced myocarditis presenting as acute STEMI (BMJ Case Reports (2015) DOI: 10.1136/bcr-2014-207151);Quetiapine-induced myocarditis presenting as acute STEMI

BMJ Case Reports

Volumn 2015, Issue , 2015, Pages

  Wassef, Nancy ^a   Khan, Nazish ^a   Munir, Shahzad ^a  

^a ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CITALOPRAM; MELATONIN; METHYLPHENIDATE; PRASUGREL; QUETIAPINE; RAMIPRIL; TROPONIN; DIBENZOTHIAZEPINE DERIVATIVE; DOPAMINE UPTAKE INHIBITOR; NEUROLEPTIC AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATTENTION DEFICIT DISORDER; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CONTRAST ENHANCEMENT; CORONARY ARTERY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; HEART LEFT VENTRICLE WALL MOTION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MALE; MYOCARDITIS; QUATIAPINE INDUCED MYOCARDITIS; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; YOUNG ADULT; ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CHEMICALLY INDUCED; DIFFERENTIAL DIAGNOSIS; MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CHEST PAIN; DIAGNOSIS, DIFFERENTIAL; DIBENZOTHIAZEPINES; DOPAMINE UPTAKE INHIBITORS; HUMANS; MALE; METHYLPHENIDATE; MYOCARDIAL INFARCTION; MYOCARDITIS; QUETIAPINE FUMARATE; TREATMENT OUTCOME;

EID: 84921668290     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2014-207151corr1     Document Type: Erratum

References (21)

1. Schultheiss HP, Kuhl U, Cooper LT. The management of myocarditis. Eur Heart J 2011;32:2616-25.
2. Munshi TA, Volochniouk D, Hassan T, et al. Clozapine-induced myocarditis: is mandatory monitoring warranted for its early recognition? Case Rep Psychiatry 2014;2014:513108.
3. Goldman L. Chapter 60 diseases of the myocardium and endocardium In: Goldman's Cecil medicine. Goldman L, Schafer AI, eds. Elsivier Publishing, 2012.
4. Cooper LT. Myocarditis. N Eng J Med 2009;360:1526-38.
5. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009;360:225-35.
6. Dadfermy S, Dixon J. A case of acute cardiomyopathy and pericarditis associated with methylphenidate. Cardiovasc Toxicol 2009;9:49-52.
7. Singh K, Xiao L, Remondino A, et al. Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol 2001;189:257-65.
8. Summary of Product Characteristics-Methylphenidate XL (Concerta) http://www. medicines.org.uk (accessed 24 Mar 2014).
9. Kronenberger WG, Giauque AL, Lafata DE, et al. Quetiapine addition in methylphenidate treatment-resistant adolescents with co-morbid ADHD, conduct/ oppositional-defiant disorder, and aggression: a prospective, open-label study. J Child Adolesc Psychopharmacol 2007;17:334-47.
10. Jensen VF, Gotzsche O. Allergic myocarditis in clozapine treatment. Ugeskr Laeger 1995;156:4151-2.
11. Raz A, Bergman R, Eilam O, et al. A case report of olanzapine-induced hypersensitivity syndrome. Am J Med Soc 2001;321:156-8.
12. Hagg S, Spigset O, Bate A, et al . Myocarditis related to clozapine treatment. J Clin Psychopharmacol 2001;21:382-8.
13. Kilian J, Kerr K, Lawrence C, et al. Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999;354:1841-5.
14. Roesch-Ely D, Van Einsiedel R, Kathöfer S, et al . Myocarditis with Quetiapine. Am J Psychiatry 2002;159:1607-8. (accessed 26 Feb 2014)
15. Quetiapine and cardiac muscle disorders. Rev Prescrire 2013;33:350.
16. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006;113:593-5.
17. Mangani JW, Dec W. Myocarditis current trends in diagnosis and treatment. Circulation 2006;113:876-90.
18. Ronaldson KJ, Fitzgerald PB, Taylor AJ, et al. Observations from 8 cases of clozapine rechallenge after development of myocarditis. J Clin Psychiatry 2012;73:252-4.
19. Ansari A, Maron BJ, Bernstson DG. Drug-induced toxic myocarditis. Tex Heart Inst J 2003;30:76-9.
20. th edn. Saunders Ltd, 2009.
21. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease; a scientific statement from the American Heart Association, the American College of Cardiology, and The European Society of Cardiology. J Am Coll Cardiol 2007;50:1914-31.